92 related articles for article (PubMed ID: 23643089)
21. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
22. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
23. dUTP pyrophosphatase expression correlates with a poor prognosis in hepatocellular carcinoma.
Takatori H; Yamashita T; Honda M; Nishino R; Arai K; Yamashita T; Takamura H; Ohta T; Zen Y; Kaneko S
Liver Int; 2010 Mar; 30(3):438-46. PubMed ID: 19968781
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of CLIP score system for patients with resection of hepatocellular carcinoma].
Zhao W; Ma Z; Zhou X; Feng Y; Fang B
Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):321-5. PubMed ID: 12133332
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
[TBL] [Abstract][Full Text] [Related]
28. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
29. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
31. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.
Sun B; Zhang S; Zhang D; Du J; Guo H; Zhao X; Zhang W; Hao X
Oncol Rep; 2006 Oct; 16(4):693-8. PubMed ID: 16969481
[TBL] [Abstract][Full Text] [Related]
32. BC047440 overexpression is a risk factor for tumor invasion and poor prognosis in hepatocellular carcinoma.
Zheng L; Huang X; Liang P; Wen Y; Yang T; Li Y; Zhao H; Han K; Li J
Hepatogastroenterology; 2010; 57(101):919-25. PubMed ID: 21033252
[TBL] [Abstract][Full Text] [Related]
33. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
34. [Expression of Nodal in hepatocellular carcinoma and its relationship with angiogenesis and epithelial-mesenchymal transition].
Chen J; Li J; Liu W; Jia W; Xu G; Ma J
Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):188-92. PubMed ID: 24785457
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
[TBL] [Abstract][Full Text] [Related]
36. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
Li Q; Liu Z; Xu M; Xue Y; Yao B; Dou C; Jia Y; Wang Y; Tu K; Zheng X; Yao Y
Cancer Lett; 2016 May; 375(1):190-198. PubMed ID: 26945969
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of nerve growth factor in primary liver cancer].
Li PY; Ke XL; Zhu Q; Tian DA
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):121-4. PubMed ID: 23663884
[TBL] [Abstract][Full Text] [Related]
38. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma].
Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma.
Ye K; Wang Z; Zhang G; Liang S
J Invest Surg; 2010 Jun; 23(3):163-9. PubMed ID: 20590388
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.
Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H
BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
